Oncosil Medical Ltd has released a press release.
Appendix 4D and Half Year Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- CEO Remuneration Update
- Capital Raising Presentation
- Prospectus
- $8.0 million Capital Raise for Ongoing Commercial Expansion
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from OncoSil Medical
- Security Class Suspension from Quotation
- Security Class Reinstatement to Quotation - OSLOE
- OncoSil Medical Receives TGA Approval in Australia
- OncoSil progresses HDE with US FDA
- OncoSil Selected for Major European Pancreatic Cancer Study
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical